Matthew Robinson

Matthew Robinson

Company: Microbiotica

Job title: VP Translational Biology


Using Precision Microbiome Profiling to Develop a Biomarker for Immune Checkpoint Inhibitor Response and a Potent Therapeutic Consortium 9:25 am

Microbiotica’s metagenomic platform in combination with a new microbiome in Melanoma has enabled identification of a microbiome signature of response to Immune Checkpoint Inhibitor consistent across four independent studies MB097 is a precision-medicine Live bacterial Therapeutic derived from a microbiome signature Human primary immune cell assays and syngeneic models have validated MB097 is being scaled…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.